Search

Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare subtype of non-Hodgkin's lymphoma of the skin. Clinically, SPTCL presents as subcutaneous tumors located on the extremities or trunk, often associated with systemic symptoms like fever or fatigue. The therapeutic regimen for SPTCL is at present not standardized. We describe herein a case of a young woman who presented with intermittent fever and skin rash and was diagnosed later with SPTCL. The case is reported here for its rarity and rapidly changing unusual clinical manifestations. This case also highlights that monotherapy with systemic steroid can be a valuable treatment option for the management of SPTCL, especially in those without hemophagocytic syndrome.

We hereby report a rare case of a 14-year-old girl presenting with asymptomatic pitted papules over the flexor aspect of her right 4th and 5th digits. This was histopathologically proven to be porokeratotic eccrine ostial and dermal duct nevus (PEODDN).

Itraconazole (ITZ) has been the mainstay of oral antifungal treatment for the current epidemic of recalcitrant dermatophytosis (RD) in India. Recently, a newer formulation of ITZ, super bioavailable itraconazole (SUBA-ITZ), is made available in the market by many pharmaceutical companies. It is important for dermatologists to understand the pharmacokinetic properties of SUBA-ITZ vis-a-vis conventional pellet formulation to use it effectively and safely. Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) has established a special interest group for recalcitrant dermatophytosis (SIG-RD) to strengthen research, continuing medical education, and industry collaboration on the subject. This position statement on SUBA-ITZ by SIG-RD is an attempt to address current pieces of evidence and the position of this new formulation in the management of RD. [ABSTRACT FROM AUTHOR]

Byline: Anindita. Sen, Deblina. Bhunia, Pijush. Datta, Atanu. Ray, Parthajit. Banerjee Background: Onychomycosis (OM) is a major public health problem which is increasing worldwide. It is associated with high morbidity [...]

Byline: Olympia. Rudra, Arghyaprasun. Ghosh, Sudip. Ghosh, Deblina. Bhunia, Prabhakar. Mandal Sir, An 8-year-old boy presented to us with a raised asymptomatic cutaneous lesion over his left leg for the [...]

Byline: Arghyaprasun. Ghosh, Deblina. Bhunia, Olympia. Rudra, Megha. Agarwal Sir, Lichen planus (LP) is a common autoimmune disorder with variable presentation. Perforating LP is a rare variant of this disease [...]

Byline: Deblina. Bhunia, Shouvik. Ghosh, Olympia. Rudra, Surajit. Biswas, Megha. Agarwal, Arghyaprasun. Ghosh Sir, Keratoacanthoma is an epithelial tumor characterized by rapid growth with a relatively benign course. Though the [...]

Objective To determine the demographic, epidemiological and clinical features and associations of different types of nevi from eastern India. Methods This descriptive study was carried out R. G. Kar Medical College and Hospital, Kolkata over 12 months (from March 2013 to February 2014). Two hundred patients of all age groups and both sexes presenting with or found to have nevi were evaluated for demographical, clinical variables and comorbidities. Results The most common type of nevus in our study was Becker's nevi and the least common was eccrine angiomatous nevus. Most common age of presentation was the first and second decades. An overall female preponderance was noted in our study. Infantile hemangioma was seen more commonly in girl children. Nevus of Ota was commoner in females. In contrast to previous findings, majority of VEN lesions were on head and neck region, followed by trunk. Most of the lesions of ILVEN affected lower half of the body. Conclusion A diverse variety of nevi were seen, more commonly in females. They usually appear in the first and second decade of life. Patients should be meticulously examined for cutaneous and systemic associations. [ABSTRACT FROM AUTHOR]

Itraconazole (ITZ) has been the mainstay of oral antifungal treatment for the current epidemic of recalcitrant dermatophytosis (RD) in India. Recently, a newer formulation of ITZ, super bioavailable itraconazole (SUBA-ITZ), is made available in the market by many pharmaceutical companies. It is important for dermatologists to understand the pharmacokinetic properties of SUBA-ITZ vis-a-vis conventional pellet formulation to use it effectively and safely. Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) has established a special interest group for recalcitrant dermatophytosis (SIG-RD) to strengthen research, continuing medical education, and industry collaboration on the subject. This position statement on SUBA-ITZ by SIG-RD is an attempt to address current pieces of evidence and the position of this new formulation in the management of RD., Competing Interests: There are no conflicts of interest., (Copyright: © 2023 Indian Dermatology Online Journal.)